BARDA Broad Agency Announcement (BAA)

BARDA BAA (through

Supports teams developing countermeasure technologies for CBRN, diagnostics, and readiness-focused therapeutics through BARDA BAA.

The BARDA Broad Agency Announcement (BAA-23-100-SOL-00004) is a multi-year, rolling solicitation issued by the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human Services. The BAA funds research and development of medical countermeasures (MCMs) against chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infectious diseases. Amendment 7, issued in March 2026, maintains 12 active Areas of Interest spanning CBRN vaccines, antivirals, antimicrobials, diagnostics, radiological and chemical MCMs, burn and blast injury treatments, and flexible therapeutic platforms. The solicitation accepts proposals on a rolling basis through 25 September 2028.

Eligible applicants include for-profit companies, non-profit organisations, universities, and research institutions operating in the United States; individual applicants are ineligible. The instrument is a procurement contract or other transaction agreement under NAICS code 541714. The submission process is two-stage: Stage 1 requires a quad chart plus abstract submitted through BARDA's Digital Resources Portal at bdr.hhs.gov; Stage 2 full proposals are issued by invitation only after BARDA evaluates Stage 1 submissions. BARDA encourages applicants to request a TechWatch meeting before submitting to receive early signal on programmatic fit before investing in a full abstract.

Winning BARDA awards requires alignment with one of the 12 named Areas of Interest as described in Amendment 7 and the associated PDF solicitation documents, which contain detailed page limits, scoring rubrics, and area-specific technical requirements not published on the landing page. Contract enquiries can be directed to BARDA-BAA@hhs.gov. The rolling structure means there is no single fixed deadline; applicants can submit Stage 1 materials at any point before September 2028, giving organisations flexibility to enter when their technology readiness level and data package best match BARDA's stated priorities.